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ABSTRACT (247 words) 
Objectives: We investigated the effects of gestational age, birthweight, small 
for gestational age (SGA) and large for gestational age (LGA) on childhood 
type 1 diabetes. 
Methods: We conducted a population-based cohort study of all singleton live 
births in Sweden between 1973-2009 and a sibling-control study. Perinatal 
data were extracted from the Swedish Medical Birth Register. Children with 
type 1 diabetes diagnosis were identified from the Swedish National Patient 
Register. Log-linear Poisson regression and conditional logistic regression 
were used for data analysis. 
Results: The study cohort consisted of 3,624,675 singleton live births 
(42,411,054 person-years). There were 13,944 type 1 diabetes cases during 
the study period. The sibling-control study consisted of 11,403 children with 
type 1 diabetes and 17,920 siblings. Gestational age between 33-36 weeks 
(RR=1.18; [95%CIs: 1.09, 1.28) and 37-38 weeks (RR=1.12; [95%CIs: 1.07, 
1.17]) was associated with type 1 diabetes in the cohort study and remained 
significant in the sibling-control study. SGA (RR=0.83; [95%CIs: 0.75, 0.93]) 
and LGA (RR=1.14; [95%CIs: 1.04, 1.24]) were associated with type 1 
diabetes in the cohort study. The SGA association remained unchanged in the 
sibling study while the LGA association disappeared. Very low birthweight 
was associated with a reduced risk of type 1 diabetes. 
Conclusions: The findings suggest a small association between gestational 
age and type 1 diabetes that is not likely due to familial confounding factors. 
Gestational age and type 1 diabetes may be related to insulin resistance due 
to early life growth restriction or altered gut microbiota in preterm babies. 
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INTRODUCTION 
 
Type 1 diabetes is a heterogeneous autoimmune disease characterized by 
destruction of pancreatic beta cells, resulting in absolute insulin deficiency (1). 
Although autoimmunity is suggested as the predominant effector mechanism, 
it is thought that type 1 diabetes precipitates in genetically susceptible 
persons due to an environmental trigger (2, 3). The prevalence of type 1 
diabetes in the USA increased from 1.4 per 1000 in 2001 to 1.93 per 1000 in 
2009 (4). Similar trends were observed in European countries (5). In Sweden 
the incidence of type 1 diabetes increased between 1978 and 2004 but 
plateaued after 2005 (6).  
 
Several studies found associations between gestational age and birthweight 
and type 1 diabetes, although the findings are inconsistent. In a recent meta-
analysis of 14 case-control studies and four cohort studies, preterm birth 
(gestational age<37 weeks) was found to increase the risk of type 1 diabetes 
by 18% (7). The authors highlighted several limitations in the literature such 
as a lack of consistent adjustment for important confounders. Although the 
majority of studies reported estimates adjusted for several important 
confounders, the adjustments varied across studies. It was noted that none of 
the included studies provided data on birthweight for gestational age. Another 
recent meta-analysis reported a 17% increased risk of type 1 diabetes among 
macrosomic infants while low birthweight was not significantly associated with 
type 1 diabetes (8). The authors noted lack of proper confounding adjustment 
as a limitation since only half of the 12 included studies provided adjusted 
estimates of the association between birthweight and type 1 diabetes. Among 
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studies that reported adjusted estimates, only three adjusted for gestational 
age, and one study adjusted for age and sex only. Significant uncertainty 
remains, however, about the presence and strength of any association 
between birthweight and type 1 diabetes (9). 
 
We aimed to examine the effects of gestational age, small for gestational age 
(SGA), large for gestational age (LGA) and birthweight on childhood type 1 
diabetes using population-based Swedish data with information on several 
potential confounders. We then performed a sibling-control study to assess 
whether any observed associations in the cohort study were likely to be 
causal. Sibling control analyses allow us to draw stronger causal inferences 
about these aspects of pregnancy (10-14). This approach is efficient in 
accounting for family factors, such as genetics and environmental factors that 
are shared by siblings. To our knowledge, this is the largest study on this topic 
to date and the first to utilize sibling control analyses to assess the effects of 
perinatal risk factors on type 1 diabetes. 
 
 
METHODS 
 
Study cohort 
The study utilised data from the Swedish national registers held by the 
Swedish National Board of Health and Welfare and Statistics Sweden. Each 
resident in Sweden is assigned a unique identifier, the Personal Identity 
Number (PIN), which enables data linkage from various registers and among 
relatives, such as parents and siblings (15). Using the Swedish Medical Birth 
Register, we identified almost all singleton live births in Sweden between 
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January 1, 1973 and December 31, 2009. This register contains obstetric, 
maternal and neonatal data on 96-99% of births in Sweden (16). The sibling-
control design study included the children with type 1 diabetes and their 
siblings. This is a matched case-control study – nested within the overall 
cohort – where the ‘case’ has type 1 diabetes, the ‘controls’ do not and the 
case and control are siblings.  
 
Exposure variables  
Gestational age and birthweight were measured at delivery and recorded in 
the Medical Birth Register. Gestational age was determined at delivery and 
calculated using dates from early second trimester ultrasound or calculated by 
menstrual dating (17) and categorized into very preterm: 22-32; preterm: 33-
36; early term: 37-38; term: 39-40 (reference group); and post-term: 41+ 
weeks. Birthweight was considered erroneous if it was recorded as <500g or 
>5500g. Birthweight was categorized into: <1500g; 1500-2499; 2500-2999; 
3000-3999 (reference group); 4000-5500g. SGA and LGA were defined 
according to the Swedish weight-based growth standards (18). SGA was 
defined as a birthweight of 2 standard deviations below the mean and LGA as 
birthweight of 2 standard deviations above the mean of the sex-specific and 
gestational age distributions. Children were classified into three categories: 
SGA, LGA and appropriate for gestational age (AGA; neither SGA nor LGA).  
 
Outcome measure 
The Swedish National Patient Register contains records of inpatient 
diagnoses in Sweden since 1964 (full national coverage since 1987) and 
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outpatient diagnoses since 2001. The date of onset of type 1 diabetes was 
defined as the date of the first hospitalization, which led to the diagnosis of 
type 1 diabetes. Childhood type 1 diabetes, before 15 years of age, was 
defined according to the International Classification of Diseases (ICD) 8 (250); 
ICD-9 (250); and ICD-10 (E10). The cohort was followed from the date of birth 
until onset of type 1 diabetes, 15th birthday, death, migration or December 31, 
2009 (end of the study period). The Migration register provided the dates of 
migration from Sweden while information on date of death was obtained from 
the Cause of Death register.  
 
Potential confounders  
Data on infant sex, maternal age, body mass index (BMI), pre-pregnancy 
diabetes and gestational diabetes, country of origin, birth order, pre-eclampsia 
and mode of delivery were obtained from the Medical Birth Register. Maternal 
BMI is measured at the first antenatal visit which takes place before 15 weeks’ 
gestation in Sweden(19). Data on maternal education level was obtained from 
the Education register which contains information on the residents’ highest 
level of completed formal education.  
 
Statistical analysis 
The statistical analysis to examine the effects of gestational age, birthweight, 
SGA and LGA on childhood type 1 diabetes was performed in two steps. First, 
log-linear Poisson regression with aggregated person-years was performed 
for each exposure variable using the entire cohort. All Poisson models were 
adjusted for offspring age, as a time dependent variable, year of birth (in one 
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year categories), birth order and sex, maternal age, BMI, pre-pregnancy 
diabetes, gestational diabetes, country of origin and education level (these 
variables were included in the models as presented in Table 1).  
The second step aimed to adjust for unmeasured familial environmental and 
genetic confounding factors shared by siblings using a sibling-control design. 
Conditional logistic regression was used for the sibling-control analyses with 
siblings identified through the Multi-Generation Register (20). The conditional 
logistic regression analysis included siblings where the control was under 
follow-up and type 1 diabetes free at the age that the sibling with type 1 
diabetes was diagnosed. In these analyses, only siblings discordant for each 
exposure variable categories as well as type 1 diabetes contributed to the 
measure of association. However, siblings concordant for the exposure 
variable categories were included in the analysis as they contribute to the 
potential confounders estimates. The models were adjusted for the same 
variables as in the Poisson models apart from maternal country of birth, which 
was the same for both siblings. A sensitivity analysis was performed including 
full siblings only in the sibling study.  
 
Additional analyses 
Considering the complex relationship between birthweight and birthweight for 
gestational age with gestational age, we repeated the birthweight for 
gestational age models restricting the analysis to children with gestational age 
of ≥37 weeks and then more than ≥39 weeks. Similarly, we repeated the 
gestational age models excluding SGA and LGA children. Between 1973 and 
1981 we were able to classify mode of delivery into unassisted vaginal 
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delivery (VD), instrumental vaginal delivery (IVD) and Caesarean section (CS) 
while from 1982 data on elective and emergency CS were available and were 
used to classify CS. Data on maternal BMI were available from 1981 onwards. 
However, more than 20% of the women who delivered their children from 
1981 onwards had missing BMI data. Therefore, we repeated the models from 
1982 onwards (to coincide with the more detailed data on mode of delivery) 
as well as models excluding all women with missing BMI. To assess the 
potential impact of missing BMI data on the observed association between 
gestational age and type 1 diabetes, we performed two Poisson regression 
models including all births from 1981 onwards with know maternal BMI. In the 
first model we removed maternal BMI and in the second model we included 
BMI (in addition to the other potential confounders as described in the Tables 
footnote). Considering that data coverage was complete at the national level 
from 1987 we repeated the statistical models including births from 1987 
onwards.  
 
Further analyses were performed excluding 1) IVD and CS; 2) children of 
mothers who had pre-eclampsia; 3) children of mothers who had pre-
gestation diabetes; 4) children of women who had gestational diabetes; 5) 
children of women who were classified as obese (BMI≥30kg/m2). We 
performed these analyses to assess whether those factors have any influence 
on the observed associations as they were found to be associated with type 1 
diabetes in previous studies (19, 21, 22). We also repeated the Poisson 
models including only-children. To examine the distributional assumption of 
the Poisson regression regarding over-dispersion, we performed negative 
9		
binomial regression models. There was no evidence to suggest the 
distributional assumption was violated therefore the Poisson models results 
are presented throughout the manuscript.  In post-hoc analyses, we repeated 
the sibling-control models excluding children of women who had pre-
gestational or gestational diabetes. Furthermore, we performed detailed post-
hoc analyses to examine the association between gestational age and type 1 
diabetes using finer gestational age categories. We repeated the Poisson 
regression analysis using gestational age categorized as 22-29 weeks and in 
one-week categories thereafter. Gestational age weeks 22-29 were combined 
in one category due to small number of cases in each week category. Finally, 
we performed sensitivity analysis to examine the potential effect of 
unmeasured confounding (see Appendix 2 for details). 
 
 
RESULTS 
 
The study cohort consisted of 3,624,675 singleton live births with known PIN 
and gender in Sweden between January 1, 1973 and December 31, 2009 
(Figure 1). During the study period (42,411,054 person-years) there were 
13,944 childhood type 1 diabetes cases. Mean age at diagnosis was 8.4 
years (8.5 in boys and 8.3 in girls). Mothers of children with type 1 diabetes 
were on average older, had a higher education level and more likely to have 
pre-pregnancy diabetes. The sibling-control study consisted of 82% 
(11403/13944) of the type 1 diabetes cases in the cohort study (sibling pairs 
discordant on type 1 diabetes). The majority of the children with type 1 
diabetes that were not included in the sibling analysis were only-children 
(2163/13944; 15.5%). The maternal characteristics in the sibling-control study 
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were similar to those of the entire cohort apart from pre-gestation and 
gestational diabetes, which were more common in the sibling-control study. 
More details are summarized in Table 1 and Table e1 (Appendix 1). 
 
Gestational age 
Gestational age was significantly associated with the risk of type 1 diabetes. 
Very preterm (RR=0.67; [95% CI: 0.53, 0.84]) and post-term (RR=0.87; [95% 
CI: 0.83, 0.90]) births were less likely to develop type 1 diabetes while preterm 
(RR=1.18; [95% CI: 1.09, 1.28]) and early term births (RR=1.12; [95% CI: 
1.07, 1.17]) were more likely to develop type 1 diabetes compared to children 
born at term (Table 2; column 4). All these associations remained statistically 
significant and almost unchanged in the sibling-control study (Table 2, column 
6).  We further performed a log-linear Poisson regression to examine the 
association between gestational age (classified into 1-week categories 
whenever possible) and type 1 diabetes (Table e2, Appendix 1). These 
findings suggested that the risk of type 1 diabetes was largest among children 
born at 34 weeks’ gestation. To assess how robust the association is in 
relation to unmeasured confounding we performed sensitivity analyses using 
different scenarios. The details of this analysis and the results are presented 
in Appendix 2.  
 
Birthweight for gestational age 
In the cohort study there were significant associations between SGA 
(RR=0.83; [95% CI: 0.75, 0.93]) and LGA (RR=1.14; [95% CI: 1.04, 1.23]) and 
the risk of type 1 diabetes (Table 3, column 4). The association between SGA 
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and type 1 diabetes remained unchanged and statistically significant in the 
sibling analysis while the association between LGA and type 1 diabetes was 
no longer statistically significant (Table 3, column 6). Restricting the cohort 
analyses to early term and term babies did not change the results of SGA or 
LGA materially.  
 
Birthweight  
Very low birthweight (<1500g) children were at lower risk of type 1 diabetes 
compared to children with normal birthweight (RR=0.66; [95% CI: 0.48, 0.91]) 
(Table 4, column 4). This association remained statistically significant in the 
sibling analysis (RR=0.50; [95% CI: 0.31, 0.80])(Table 4, column 6). Further 
adjustment for gestational age in the sibling control model reduced the 
association slightly (RR=0.59, [95% CI: 0.33, 1.07]). The other birthweight 
categories were not associated with type 1 diabetes with most RRs close to 
unity (Table 4). Of the very low birthweight children 95% were born before 37 
weeks’ gestation (16,506/17,333). When the analysis was restricted to 
children born before 37 gestation weeks, the association between very low 
birthweight (RR=0.47, [95% CI: 0.32, 0.67]) and low birthweight (RR=0.73, 
[95% CI: 0.60, 0.88]) and type 1 diabetes was statistically significant with 
larger effect size, although the statistical interaction terms between 
birthweight and gestational age categories were not statistically significant (p-
value for interaction>0.05).  
 
Additional analyses 
12		
When the models were repeated for births from 1987 onwards at the cohort 
level the findings were not materially changed compared to the full cohort 
models (data not shown). When we repeated the cohort analyses for all the 
exposure variables excluding birth before 1981 and then excluding all births 
with missing BMI data, no material change was observed. Repeating the 
analysis using data on full siblings only did not change the results materially. 
Additional cohort analyses on the three exposure variables were performed 
restricting to 1) only-children ; 2) AGA children; 3) unassisted vaginal delivery; 
4) mothers with no pre-pregnancy diabetes; 5) mothers with no gestational 
diabetes; 6) non-obese mothers; and 7) mothers with no pre-eclampsia (Table 
e3, Appendix 1). Overall, none of these restrictions had any material effect on 
the findings. Restricting the Poisson models to the first two children per 
mother did not change the results materially. Excluding diabetes and 
gestational diabetes from the sibling models did not explain any of the 
observed associations.  
 
DISCUSSION 
This study investigated the effects of gestational age, birthweight, SGA and 
LGA on the risk of childhood type 1 diabetes using a large population-based 
cohort including nearly all births in Sweden over four decades. We used a 
unique approach by applying both cohort and sibling-control designs using the 
same population. Preterm and early term birth were associated with an 
increased risk of type 1 diabetes in the cohort study while very preterm, post-
term, SGA and very low birthweight were associated with a reduced risk of 
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type 1 diabetes. All these associations remained significant in the sibling-
control study suggesting a potential causal association.  
LGA was associated with an increased risk of type 1 diabetes in the cohort 
analysis but the association disappeared in the sibling analysis, which 
suggests that familial factors that are shared between siblings such as 
genetics and environmental factors might explain, at least partly, this 
association. There was very little evidence to support an association between 
birthweight of 1,500 grams or greater and type 1 diabetes. 
 
Comparison with previous literature 
The existing literature on birthweight and gestational age and type 1 diabetes 
is inconsistent. A recent systematic review and meta-analysis identified 18 
studies on the association between gestational age and type 1 diabetes (7). 
Interestingly, all the identified studies were published in the last two decades, 
reflecting the increasing interest in the effect of perinatal risk factors on type 1 
diabetes. The present finding that preterm birth increases the risk of type 1 
diabetes in the cohort study is almost the same as the pooled estimate from 
the meta-analysis. However, the meta-analysis did not report data on very 
preterm, early term or post term and type 1 diabetes. Another meta-analysis 
suggested that birthweight>4,000 grams increases the risk of type 1 diabetes 
by 43% (8). This is inconsistent with the findings of the present study as we 
found no evidence for type 1 diabetes increased risk among children born with 
birthweight>4,000 grams. Although LGA children were found to have 14% 
increased risk of type 1 diabetes in the cohort study, this association was not 
consistent with a causal association in the sibling analysis. Our findings on 
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low birthweight, however, are consistent with the meta-analysis especially 
when we restricted the low birthweight analysis to preterm births. Robertson 
and Harrild reported no association between maternal and neonatal risk 
factors including birthweight and gestational age and type 1 diabetes in a 
matched case-control study (23). It should be noted that they found increased 
odds of type 1 diabetes in children born preterm (<37 weeks) or with low 
birthweight (<2500 grams), although the results were not statistically 
significant. This suggests that the apparently inconsistent findings could be 
related to lack of adequate statistical power in Robertson and Harrild (23). 
Additionally, we categorized both birthweight and gestational age into more 
tightly defined groups including very low birthweight and very preterm birth 
while they used preterm birth as <37 weeks and low birthweight as <2500 
grams, which makes the comparison more complicated. The observed 
association between gestational age and type 1 diabetes is consistent with a 
large population-based study from Western Australia, which found increased 
risk of type 1 diabetes in preterm and early term children (24). Haynes et al., 
also reported a small association between increased birthweight and 
increased birthweight for gestational age and higher risk of type 1 diabetes, 
while we found little evidence for such an association. In another large 
population-based study from Northern Ireland, Cardwell et al., reported an 
increased risk of type 1 diabetes with higher birthweight which is not 
consistent with our findings (25). Comparing our gestational age finding, 
however, is more difficult as Cardwell et al., categorized gestational age as 
<39 (reference group); 39; 40 and ≥41 weeks’ gestation. Contrary to the 
present findings, Dahlquist et al., (1999), reported no association between 
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gestational age and type 1 diabetes in the EURODIAB study which included 
data from seven European studies (26). They also reported reduced risk of 
type 1 diabetes in low birthweight children but not SGA babies. To our 
knowledge, ours is the first study to perform a sibling-control study nested 
within a cohort on this topic, therefore there are no other studies to compare 
our results.  
 
Strengths and limitations 
This study has several strengths. First, the study was based on a very large 
population-based data of 3.6 million children born in Sweden over four 
decades, which is, to our knowledge, the most comprehensive study on this 
topic. Second, the data obtained from the national registers were 
prospectively collected therefore the data on the outcome, exposures and 
potential confounders are not subject to recall bias. Third, the type 1 diabetes 
diagnoses were based on ICD-8, 9 and 10 with a known and accurate date of 
first hospitalization, which is considered the date of diagnosis. Data on type 1 
diabetes in Sweden is known to be of very high quality (27). Fourth, we were 
able to adjust for several potential confounders, which were adjusted for in 
previous studies. Finally, in addition to the conventional cohort analyses, 
sibling control analyses were performed. It is worth noting that the sibling 
design study can rule out a number of potential explanations for observed 
associations compared to observational designs using unrelated controls. 
Moreover, sibling design studies may play an important role in assessing 
potentially causal associations. In the present study, statistical models of the 
sibling-control study allowed us to adjust for unmeasured factors that are 
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shared by siblings such as family environment, diet, lifestyle, maternal 
characteristics and genetic factors.  
 
The following limitations should be considered when interpreting the study 
findings. First, we used data on almost all births in Sweden from 1973 and 
complete nationwide coverage on diagnoses was not achieved until 1987. 
However, our sensitivity analyses showed that restricting the data to births 
from 1987 onwards were consistent with the overall results. Second, although 
we had access to several potential confounders, there was lack of data on 
several others. For example, we had no data on maternal life style during 
pregnancy such as physical activity, diet and weight gain. Excessive weight 
gain during pregnancy, maternal nitrite intake and cod liver oil 
supplementation have been associated with the risk of type 1 diabetes (28). 
Furthermore, we had no data on parental and family life style such as family 
diet and attitude to acquiring health care. However, the risk of residual 
confounding was reduced by the sibling control analyses. Sibling control 
statistical models are effective in adjusting for unmeasured familial 
characteristics that are shared by siblings i.e. maternal and paternal factors 
that were fixed for each family across pregnancies. Although, these methods 
cannot rule out unmeasured confounding factors that simultaneously vary 
between siblings i.e. parental factors that are not permanently fixed for each 
family and could potentially be different for different pregnancies (29).  
 
Potential mechanisms 
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It has been hypothesized that the effect of preterm and early term birth on the 
risk of type 1 diabetes may be related to fetal growth restriction (7). Our data 
however, do not support this hypothesis, as the association was unchanged 
when SGA children were excluded from the analysis. Another hypothesis 
suggests that preterm children may have experienced growth restriction in 
early life and the catch-up growth may result in later insulin resistance (30). It 
is possible that preterm births experience structural change within organ 
systems and epigenetic changes leading to higher risk of type 1 diabetes. The 
observed associations between preterm and early term birth and type 1 
diabetes are unlikely to be related to maternal diabetes as this was corrected 
for in the cohort and sibling analyses. Notably, the results remained 
unchanged when women with pre-gestation or gestational diabetes were 
excluded from the analyses. Finally, preterm children have been suggested to 
have an altered microbiota, which may play a role in the development of type 
1 diabetes (31). Kostic et al., performed a study to examine the link between 
human gut microbiome in infancy and type 1 diabetes in 33 infants genetically 
predisposed to type 1 diabetes (32). They found a marked drop in alpha-
diversity in type 1 diabetes progressors between seroconversion and type 1 
diabetes diagnosis. It is interesting that very preterm and very low birthweight 
babies have been suggested also to have an altered microbiota but they were 
not associated with an increased risk of type 1 diabetes in the present study 
(31). Indeed very preterm, SGA and very low birthweight babies appeared to 
have significantly lower risk of type 1 diabetes. The effects of very preterm 
and very low birthweight on type 1 diabetes were not studied thoroughly in the 
past as such a study of rare exposure and rare outcome would require large 
18		
cohorts. The biological mechanism of this association is not known but It is 
possible that it is due to fetal programming where the most vital organs are 
protected. These findings are worth replicating in other populations as they 
may generate further hypotheses on the effect of perinatal risk factors on type 
1 diabetes. 
 
Conclusion 
We found that preterm and early term babies are at increased risk of type 1 
diabetes while very preterm birth, very low birthweight and SGA babies at 
reduced risk of type 1 diabetes. The sibling study suggested that these 
associations, although small, were not due to familial factors shared by 
siblings. Further research is warranted to replicate these findings and 
understand the potential biological mechanisms.  
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Figure 1: Flowchart of study population 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                            
 
  
 
 
 
 
 
 
 
 
 
 
 
 
3,731,304 births (1973-2009) 
Exclusions: 
12,105 stillbirths; 90,219 multiple births; 98 
unknown infant sex; 9 children with missing 
maternal unique PIN;  
 
4198 were excluded because their follow-up 
ended on the same day of birth (4021 children 
died on the first day of life and 177 were born on 
31 December 2009). 
3,624,675singleton live births 
with known sex and known 
maternal PIN 
Gestational age analysis 
N=3,616,628 
8047 births with missing gestational age 
 
Birthweight for gestational age analysis 
N=3,605,655 
19,020 births with missing birthweight and/or gestational age 
 
Birthweight 
N=3,614,763 
9,912 births with missing birthweight 
13944 children with Type 1 diabetes 
 
21,488 children with any Diabetes 
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Table 1: maternal characteristics in relation to childhood type 1 diabetes 
 
Potential 
confounders 
Cohort Study Sibling Study 
 No type 1 diabetes 
n(%) 
 
Childhood 
type 1 
diabetes, n(%) 
 
No type 1 
diabetes n(%) 
 
Childhood type 1 
diabetes, n(%) 
 
 n=3,610,731 n=13,944 n=17,920 n=11,403 
Maternal Age      
<20 119,097  (3.3) 392 (2.8) 734 (4.1) 332 (2.9) 
20-24 759,591  (21.0) 2,986 (21.4) 4,229 (23.6) 2,567 (22.5) 
25-29 1,276,985  (35.4) 5,042 (36.2) 6,246 (34.8) 4,207 (36.9) 
30-34 987,944  (27.4) 3,762 (27.0) 4,410 (24.6) 3,022 (26.5) 
35-39 394,022  (10.9) 1,498 (10.7) 1,948 (10.9) 1,105 (9.7) 
40+ 73,092  (2.0) 264 (1.9) 353 (2.0) 170 (1.5) 
Maternal BMI 
(1982-2009) 
(kg/m2) 
    
Normal  1,368,687 (37.9) 5,006 (35.9) 6,507 (36.3) 4,326 (37.9) 
Underweight  84,234  (2.3) 288 (2.1) 459 (2.6) 257 (2.2) 
Overweight 416,586  (11.5) 1,551 (11.1) 2,082 (11.6) 1,331 (11.7) 
Obese 155,200  (4.3) 592  (4.2) 825 (4.6) 503 (4.4) 
Missing  717,041 (19.9) 3,342 (24.0) 4,458 (24.9) 2,891 (25.3) 
Births before 1981 868,983  (24.1) 3,165 (22.7) 3,589 (20.0) 2,095 (18.4) 
Maternal 
Education 
    
≤9 years 743,753 (20.6) 2,975  (21.3) 4,003 (22.3) 2,230 (19.6) 
High school 1,592,921 (44.1) 7,012  (50.3) 8,731 (48.7) 5,813 (51.0) 
University 920,961 (25.5) 3,257  (23.4) 3,907 (21.8) 2,760 (24.2) 
Missing  353,096  (9.8) 700  (5.0) 1,279 (7.1) 600 (5.3) 
Maternal 
Country of birth 
  
  
Sweden 3,072,713 (85.1) 12,747 (91.4) 16,355 (91.3) 10,484 (91.9) 
Other Nordic 150,938 (4.2) 573 (4.1) 703 (3.9) 436 (3.8) 
Other 387,080 (10.7) 624 (4.5) 862 (4.8) 483 (4.2) 
Maternal Pre-
gestation 
diabetes 
    
No 3,593,342 (99.5) 13,595 (97.5) 17,572 (98.1) 11,160 (97.9) 
Yes 17,389 (0.5) 349 (2.5) 348 (1.9) 243 (2.1) 
Maternal 
Gestational 
diabetes 
    
No 3,590,867 (99.5) 13,695 (98.2) 17,667 (98.8) 11,229 (98.5) 
Yes 19,864 (0.5) 249 (1.8) 253 (1.4) 174 (1.5) 
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Table 2: The association between gestational age and childhood type 1 diabetes  
 
Gestational age, 
weeks 
Type 1 
diabetes
, n  
Partially adjusted, 
RR(95% CI)a 
Adjusted,  
RR(95% CI)b 
Type 1 
diabetes, 
nd 
Sibling study with 
full adjustment, 
RR(95% CI)c 
 
      
Very preterm: 22-32 72 0.71(0.56, 0.90) 0.67(0.53, 0.84) 54 0.57(0.39, 0.83) 
Preterm: 33-36 716 1.26(1.17, 1.36) 1.18(1.09, 1.28) 551 1.16(1.02, 1.32) 
Early term: 37-38 2,785 1.14(1.09, 1.19) 1.12(1.07, 1.17) 2,245 1.10(1.03, 1.18) 
Term: 39-40 7,082 Reference [1] Reference [1] 5,856 Reference [1] 
Post-term: ≥41 3,260 0.88(0.84, 0.91) 0.87(0.83, 0.90) 2,677 0.93(0.87, 1.00) 
 
a The model was adjusted for offspring age and year of birth as time dependent variables 
b The model was adjusted for offspring age as time dependent variables, year of birth, maternal age, education, BMI, country of 
origin, pre-gestation diabetes, gestational diabetes and infant sex. Covariates were included in the models categorized as 
presented in Table 1. Year of birth was included in the models as categorical in one year categories. Offspring age was included in 
the Poisson models as a time-dependent variable. 
 
c adjusted as in b without maternal country of origin 
d number of TYPE 1 DIABETES cases in sibling pairs discordant on the outcome 
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Table 3: The association between birthweight for gestational age and childhood type 1 diabetes  
 
 
Birthweight for 
gestational age 
Type 1 
diabetes, 
n  
Partially 
adjusted, 
RR(95% CI)a 
Adjusted, 
RR(95% CI)b 
Type 1 
diabet
es, nd 
Sibling study with full 
adjustment, RR(95% CI)d 
 
Birthweight for 
gestational age 
     
AGA 12,969 Reference [1] Reference [1] 10,634 Reference [1]  
SGA 329 0.84(0.75, 0.93) 0.83(0.75, 0.93) 235 0.83(0.69, 0.99) 
LGA 586 1.31(1.21, 1.42) 1.14(1.04, 1.24) 489 1.00(0.87, 1.15) 
 
a The model was adjusted for offspring age and year of birth as time dependent variables 
b The model was adjusted for offspring age as time dependent variables, year of birth, maternal age,  
education, BMI, country of origin, pre-gestation diabetes, gestational diabetes and infant sex. Covariates were included in the 
models as presented in Table 1.	Year of birth was included in the models as categorical in one year categories. Offspring age was 
included in the Poisson models as a time-dependent variable. 
c adjusted as in b without maternal country of origin 
d number of TYPE 1 DIABETES cases in sibling pairs discordant on the outcome 
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Table 4: The association between birthweight and childhood type 1 diabetes  
 
 
Birthweight 
(in grams) 
Type 1 
diabetes, n  
Partially 
adjusted, 
RR(95% CI)a 
Adjusted, 
RR(95% CI)b 
Type 1 
diabetes, 
nd 
Sibling cohort full 
adjustment, 
RR(95% CI)d 
 
<1500 39 0.70(0.51,0.96) 0.66(0.48,0.91) 28 0.50(0.31, 0.80) 
1500-2499 383 0.97(0.88,1.08) 0.95(0.86,1.05) 289 0.94(0.80, 1.12) 
2500-2999 1,534 1.01(0.95,1.06) 1.02(0.97,1.08) 1,168 1.03(0.94, 1.13) 
3000-3999 9,351 Reference [1] Reference [1] 7,705 Reference [1] 
4000-5500 2,610 1.06(1.01,1.11) 1.01(0.96,1.05) 2,193 0.94(0.87, 1.01) 
 
a The model was adjusted for offspring age and year of birth as time dependent variables 
b The model was adjusted for offspring age as time dependent variables, year of birth, maternal age,  
education, BMI, country of origin, pre-gestation diabetes, gestational diabetes and infant sex. Covariates were included in the 
models as presented in Table 1.	Year of birth was included in the models as categorical in one year categories. Offspring age was 
included in the Poisson models as a time-dependent variable. 
 
c adjusted as in b without maternal country of origin 
d number of TYPE 1 DIABETES cases in sibling pairs discordant on the outcome 
 
 
 
 
 
 
 
